Phoenix Biotech Acquisition Corp. announced a private placement of non-convertible promissory note for gross proceeds of $1,500,000 on December 16, 2022. The transaction includes participation from Phoenix Biotech Sponsor, LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 USD | -7.64% |
|
-19.35% | -97.36% |
1st Jan change | Capi. | |
---|---|---|
-97.36% | 4.73M | |
+15.85% | 121B | |
+18.91% | 112B | |
+4.43% | 22.57B | |
-18.63% | 20.82B | |
-13.76% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+1.75% | 13.17B | |
+28.07% | 11.11B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. announced that it expects to receive $1.5 million in funding